episode-header-image

Aug 2021

18m 34s

Coronapod: COVID boosters amidst global ...

SPRINGER NATURE LIMITED

About this episode

Several wealthy nations have announced plans to give third vaccine doses in a bid to help increase the protection of their most vulnerable citizens - but the science is not clear on whether this strategy will be effective or indeed necessary. Meanwhile with limited vaccine supplies - billions around the world still have no access to vaccines at all. In this episode of Coronapod we discuss the science of boosters, the stark reality of vaccine disparity and what this means for the future of the pandemic.

News: COVID boosters for wealthy nations spark outrage

News feature: COVID vaccine boosters: the most important questions

Coronapod: the inequality at the heart of the pandemic

Coronapod: the biomarker that could change COVID vaccines

Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Hosted on Acast. See acast.com/privacy for more information.

Up next

The biggest 'Schrödinger's cat' yet — physicists put 7,000 atoms in superposition

00:46 Protein-sized superposition surpasses previous experimentsNature: Pedalino et al.News: Schrödinger's cat just got bigger: quantum physicists create largest ever 'superposition'11:46 Research HighlightsNature: Ancient pottery reveals early evidence of mathematical thinkingNa ... Show More

Briefing Chat: Can NASA return rocks from Mars? And why dogs have long ears

In this episode:00:40 The rock samples destined to remain on MarsNature: NASA won’t bring Mars samples back to Earth: this is the science that will be lost05:24 The genetics of dogs’ droopy earsNature: Do their ears hang low? The genetics of dogs’ adorable floppy earsSubscribe to ... Show More

AI can turbocharge scientists' careers — but limit their scope

In this episode:00:47 AI can boost research productivity — at what cost?Research article: Hao et al.10:10 Research HighlightsNature: Ancient ‘snowball’ Earth had frigidly briny seasNature: Putting immune cells into ‘night mode’ reduces heart-attack damage12:41 JWST images are ful ... Show More

Recommended Episodes

The Evidence: When will the pandemic end?

Everybody hopes that the new super-charged Omicron variant of coronavirus will be less severe, but even if it is, it’s spreading so fast and infecting so many people, health services around the world could still buckle under the strain.Two years into the pandemic, Claudia Hammond ... Show More

The Race for a Vaccine

<p>Scientists are racing to make a vaccine for the coronavirus, collaborating across borders in what is usually a secretive and competitive field. But their cooperation has been complicated by national leaders trying to buy first claim on any breakthrough. Today, we explore how t ... Show More

Covipod #9 : Le vaccin, moins efficace chez certaines personnes

<p>Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autou ... Show More

The State of Vaccinations

<p>The United States has never undertaken a vaccination campaign of the scale and speed of the Covid-19 program. Despite a few glitches, the country appears to be on track to offer shots to all adults who want one by May 1.</p><p>We look at the ups and downs in the American vacci ... Show More

Vaccine hesitancy, the next pandemic hurdle

As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More

How close are we to a vaccine for Covid-19?

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now in development. Most vaccines take years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine at reco ... Show More